Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
An Sist Sanit Navar ; 30 Suppl 2: 7-19, 2007.
Artigo em Espanhol | MEDLINE | ID: mdl-17898825

RESUMO

Tuberculosis, that "old acquaintance of Pneumology", is still a disease with a high morbidity and mortality in the world. This is why, in spite of our having entered the XXI century, it continues to demand our attention, great challenges continue to be faced, such as bringing it under control, and new problems continue to arise, such as the emergence of multiresistant tuberculosis. Thus, for the World Health Organisation, it represents a disease of great importance that has led this body to develop a specific and ambitious program that aims at its eradication by the year 2050. In this article we detail some of the most interesting aspects of the epidemiology of this disease, with special attention paid to the problem of multiresistant tuberculosis, and we present up to date data on the morbidity and mortality of tuberculosis in the world.


Assuntos
Tuberculose/epidemiologia , Saúde Global , Humanos , Tuberculose/prevenção & controle , Tuberculose/transmissão , Tuberculose Resistente a Múltiplos Medicamentos/epidemiologia
2.
An. sist. sanit. Navar ; 30(supl.2): 7-19, 2007. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-056269

RESUMO

La tuberculosis, “vieja conocida de la Neumología”, constituye todavía una enfermedad con una alta morbimortalidad en el mundo lo que hace que, pese a estar en el siglo XXI, continúe recabando nuestra atención, se planteen grandes retos como el control de la misma y surgan nuevos problemas como la emergencia de la tuberculosis multirresistente. Así pues, constituye para la Organización Mundial de la Salud una enfermedad de gran interés que le ha llevado a desarrollar un programa específico y ambicioso que pretende su erradicación para el año 2050. En este capítulo detallamos algunos de los aspectos más interesantes de la epidemiología de esta enfermedad, con una atención especial para el problema de la tuberculosis multirresistente y se exponen datos actual


Tuberculosis, that “old acquaintance of Pneumology”, is still a disease with a high morbidity and mortality in the world. This is why, in spite of our having entered the XXI century, it continues to demand our attention, great challenges continue to be faced, such as bringing it under control, and new problems continue to arise, such as the emergence of multiresistant tuberculosis. Thus, for the World Health Organisation, it represents a disease of great importance that has led this body to develop a specific and ambitious program that aims at its eradication by the year 2050. In this article we detail some of the most interesting aspects of the epidemiology of this disease, with special attention paid to the problem of multiresistant tuberculosis, and we present up to date data on the morbidity and mortality of tuberculosis in the world


Assuntos
Masculino , Feminino , Humanos , Tuberculose/epidemiologia , Tuberculose/história , Indicadores de Morbimortalidade , Tuberculose Resistente a Múltiplos Medicamentos/epidemiologia , Fatores de Risco , Infecções por HIV/epidemiologia , Síndrome de Imunodeficiência Adquirida/epidemiologia , Espanha/epidemiologia , Tuberculose/etiologia , Fatores Socioeconômicos , Europa (Continente)/epidemiologia , Estados Unidos/epidemiologia
3.
An Sist Sanit Navar ; 28 Suppl 1: 37-44, 2005.
Artigo em Espanhol | MEDLINE | ID: mdl-15915170

RESUMO

Asbestosis is a diffuse interstitial pulmonary fibrosis, secondary to the inhalation of asbestos fibres. There is a dose-response relationship between exposure to asbestos and the risk of developing asbestosis, in such a way that the greater the exposure, the greater the risk of developing the disease. The time of clinical latency is inversely proportional to the level of exposure. Dyspnoea upon exertion and a dry cough together with end-inspiratory crackles are the most frequent symptoms and signs. Chest radiography is a basic tool in identifying the disease, however high resolution CAT has added greater sensitivity. Tests of the respiratory function show alterations and restrictive ventilations with a reduction of pulmonary spread. Determination of asbestos bodies in BAL is an indicator of exposure, although their absence does not rule out the disease. A histopathological diagnosis is the most reliable, although in the majority of cases the diagnosis is established on the basis of the existence of an antecedent of exposure to asbestos together with suggestive clinical, radiological and functional findings, and a suitable time of latency, without having recourse to a pulmonary biopsy.


Assuntos
Asbestose/patologia , Pulmão/patologia , Asbestose/epidemiologia , Biópsia , Tosse/epidemiologia , Humanos , Fatores de Risco
4.
An. sist. sanit. Navar ; 28(supl.1): 37-44, 2005. tab
Artigo em Espanhol | IBECS | ID: ibc-038441

RESUMO

La asbestosis es una fibrosis pulmonar intersticialdifusa secundaria a la inhalación de fibras de asbesto.Existe una relación dosis respuesta entre la exposicióna asbesto y riesgo de desarrollar asbestosis, de talforma que a mayor exposición, mayor riesgo de desarrollarla enfermedad. El tiempo de latencia clínica esinversamente proporcional al nivel de exposición. Ladisnea de esfuerzo y la tos seca junto con los crepitantesinspiratorios tardíos son los síntomas y signos másfrecuentes. La radiografía de tórax constituye un instrumentobásico en la identificación de la enfermedad,no obstante el TAC de alta resolución ha añadido unamayor sensibilidad. Las pruebas de función respiratoriamuestran alteraciones ventilatorias restrictivas condisminución de la difusión pulmonar. La determinaciónde cuerpos de asbesto en BAL es un indicador de exposiciónaunque su ausencia no descarta enfermedad. Eldiagnóstico de certeza es histopatológico aunque en lamayor parte de los casos se establece el diagnósticobasándose en la existencia de antecedente de exposicióna asbesto junto con hallazgos clínicos, radiológicosy funcionales sugestivos y tiempo de latencia adecuadosin recurrir a la biopsia pulmonar


Asbestosis is a diffuse interstitial pulmonaryfibrosis, secondary to the inhalation of asbestos fibres.There is a dose-response relationship betweenexposure to asbestos and the risk of developingasbestosis, in such a way that the greater the exposure,the greater the risk of developing the disease. The timeof clinical latency is inversely proportional to the levelof exposure. Dyspnoea upon exertion and a dry coughtogether with end-inspiratory crackles are the mostfrequent symptoms and signs. Chest radiography is abasic tool in identifying the disease, however highresolution CAT has added greater sensitivity. Tests ofthe respiratory function show alterations andrestrictive ventilations with a reduction of pulmonaryspread. Determination of asbestos bodies in BAL is anindicator of exposure, although their absence does notrule out the disease. A histopathological diagnosis isthe most reliable, although in the majority of cases thediagnosis is established on the basis of the existence ofan antecedent of exposure to asbestos together withsuggestive clinical, radiological and functional findings,and a suitable time of latency, without having recourseto a pulmonary biopsy


Assuntos
Humanos , Asbestose/diagnóstico , Asbestose/história , Asbestose/patologia , Asbestose , Asbestose/terapia , Amiantos Anfibólicos/efeitos adversos , Asbestos Serpentinas/efeitos adversos , Radiografia Torácica , Testes de Função Respiratória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA